Skip Navigation
MUSC mobile menu

Lab Chat: GARP and immune tolerance

Understanding the role of GARP in immune tolerance

Caroline Wallace in laboratory
Recent Ph.D. graduate, Caroline Wallace, serves as lead author on the study published in JCI Insight. Photo by Dawn Brazell
Staff Report | | April 19, 2018

Results from a recent study looking at the role of the protein GARP in immune tolerance was published in JCI Insight earlier this month. Lead author Caroline Wallace, Ph.D. describes in this Hollings Cancer Center (HCC) Lab Chat series how this study helps set the stage to better understand the immune system and how the findings may apply to diseases such as cancer and autoimmunity.

What was unique about the study and what did you find?

B cells regulate many biological functions, including helping fight infections, while maintaining tolerance to food and self-tissues. We looked at the role of GARP in B cells as the functions of this protein had not been previously studied in this immune population.  We discovered that when B cells properly express GARP, normal B cell function is maintained. Without GARP, we found that spontaneous autoimmune disease occurred.

Why is this important?

One of the most exciting findings from the study was the importance of GARP in B cells found in the gut compared to other parts of the body. Without GARP, the number of B cells expanded, producing more antibodies, which led to a loss of tolerance. For example, most of us don’t have reactions to what we eat because of multiple biological regulatory functions that are in place. We found that GARP is an additional regulatory protein that B cells use to protect the body against abnormal cell activity.

What’s next for this research?

The discovery that GARP regulates B cell tolerance can also be applied to other diseases, such as cancer. We need to better understand the role of B cells in GARP in the tumor microenvironment. In cancer, you need the immune system to fight the disease. If there is too much immune suppression, which GARP likely affects, that changes the body’s ability to fight the cancer.

Want to know more?

Zihai Li, M.D., Ph.D., discusses a novel pathway that regulates B cell tolerance.

Wallace is a recent Ph.D. graduate in the laboratory of Zihai Li, M.D., Ph.D., a cancer immunologist at HCC at the Medical University of South Carolina (MUSC). Li serves as chair of MUSC’s Department of Microbiology and Immunology and is co-leader of the Cancer Immunology Research Program at HCC, South Carolina’s only National Cancer Institute-designated Cancer Center. The Li laboratory studies the mechanisms that regulate both the adaptive and innate immune systems and how they function in cancer and autoimmune disease.

Researcher creates 'Instagram' of immune system, blending science and technology (MUSC News, Mar. 7, 2018)

A molecule that balances the immune system in the gut (MUSC News, Jun. 23, 2017)

Immunotherapy causes paradigm shift in cancer treatment (MUSC News, Jul. 19, 2016)

More Hollings Cancer Center News

Suggest a story




View MUSC's Facebook page Follow MUSC on Twitter View the MUSC Health Youtube channel Read the MUSC Health blog circle arrow MUSC_TAG_SOLID_1C